{"id":"W3134813321","doi":"10.1186/s12885-021-08003-3","title":"Pre-clinical study of IRDye800CW-nimotuzumab formulation, stability, pharmacokinetics, and safety","year":2021,"lang":"en","type":"review","venue":"BMC Cancer","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"ca_institutions":"Royal University Hospital; University of Saskatchewan","funders":"Western Economic Diversification Canada","keywords":"Nimotuzumab; Medicine; Pharmacokinetics; Monoclonal antibody; Toxicity; Pharmacology; Epidermal growth factor receptor; Antibody; Oncology; Internal medicine; Cancer; Immunology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00157156,0.0004316318,0.003075285,0.0001670493,0.00006295976,0.00002901947,0.0002730177,0.0003486827,0.00285497],"category_scores_gemma":[0.0007031724,0.0003506471,0.000413306,0.0006288849,0.0001796004,0.00005112642,0.0004303997,0.0009721373,0.000009797961],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006449601,"about_ca_system_score_gemma":0.004430652,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006776219,"about_ca_topic_score_gemma":0.001114774,"domain_scores_codex":[0.9949532,0.0007699035,0.001942198,0.0009405118,0.0009760209,0.0004181846],"domain_scores_gemma":[0.9966418,0.0008929051,0.000487703,0.001026533,0.0006191993,0.0003318855],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000213273,0.0008555345,0.02203874,0.04271952,0.000625696,0.00001792549,0.0002902685,0.0000025948,5.260327e-7,0.000009570616,0.003799783,0.9294266],"study_design_scores_gemma":[0.002955882,0.0007239986,0.006028543,0.01155184,0.00233348,0.00002133047,0.0001067064,0.00003830207,0.00000488108,0.000004560624,0.9759347,0.0002957339],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001953164,0.9917299,0.00003611982,0.00003882551,0.0006043778,0.004707738,0.0002421956,0.00003665621,0.0006509912],"genre_scores_gemma":[0.00122086,0.9958903,0.000204731,0.00003745013,0.0009123992,0.0004850359,0.0000937081,0.0001040266,0.001051489],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9721349,"threshold_uncertainty_score":0.9998946,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3541460664967972,"score_gpt":0.5736643055672753,"score_spread":0.2195182390704781,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}